Yihan Li
Stock Analyst at Barclays
(2.57)
# 2,784
Out of 4,345 analysts
40
Total ratings
75%
Success rate
8.1%
Average return
Main Sectors:
Stocks Rated by Yihan Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: IPN Ipsen S.A. | Maintained: Hold | €170.00 | $157.20 | +8.14% | 12 | May 19, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $87 → $66 | $50.82 | +29.93% | 2 | May 11, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 155.00 | $162.75 | -4.76% | 21 | Dec 8, 2025 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 375.00 | $285.40 | +31.39% | 2 | Nov 28, 2025 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 275.00 | $327.70 | -16.08% | 3 | Oct 24, 2025 |
Ipsen S.A.
May 19, 2026
Maintained: Hold
Price Target: €170.00
Current: $157.20
Upside: +8.14%
Zealand Pharma A/S
May 11, 2026
Maintained: Buy
Price Target: $87 → $66
Current: $50.82
Upside: +29.93%
Galderma Group AG
Dec 8, 2025
Maintained: Buy
Price Target: CHF 155.00
Current: $162.75
Upside: -4.76%
Novo Nordisk A/S
Nov 28, 2025
Maintained: Hold
Price Target: kr 375.00
Current: $285.40
Upside: +31.39%
Roche Holding AG
Oct 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: $327.70
Upside: -16.08%